JP2020517671A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517671A5 JP2020517671A5 JP2019557637A JP2019557637A JP2020517671A5 JP 2020517671 A5 JP2020517671 A5 JP 2020517671A5 JP 2019557637 A JP2019557637 A JP 2019557637A JP 2019557637 A JP2019557637 A JP 2019557637A JP 2020517671 A5 JP2020517671 A5 JP 2020517671A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- antibody
- pharmaceutical composition
- seq
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023077997A JP2023113655A (ja) | 2017-04-28 | 2023-05-10 | 小児の障害を処置する方法 |
| JP2026045046A JP2026120554A (ja) | 2017-04-28 | 2026-03-18 | 小児の障害を処置する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762492031P | 2017-04-28 | 2017-04-28 | |
| US62/492,031 | 2017-04-28 | ||
| PCT/US2018/029579 WO2018200818A2 (en) | 2017-04-28 | 2018-04-26 | Method of treating pediatric disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077997A Division JP2023113655A (ja) | 2017-04-28 | 2023-05-10 | 小児の障害を処置する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020517671A JP2020517671A (ja) | 2020-06-18 |
| JP2020517671A5 true JP2020517671A5 (cg-RX-API-DMAC10.html) | 2021-06-17 |
Family
ID=62455814
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019557637A Withdrawn JP2020517671A (ja) | 2017-04-28 | 2018-04-26 | 小児の障害を処置する方法 |
| JP2023077997A Pending JP2023113655A (ja) | 2017-04-28 | 2023-05-10 | 小児の障害を処置する方法 |
| JP2026045046A Pending JP2026120554A (ja) | 2017-04-28 | 2026-03-18 | 小児の障害を処置する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077997A Pending JP2023113655A (ja) | 2017-04-28 | 2023-05-10 | 小児の障害を処置する方法 |
| JP2026045046A Pending JP2026120554A (ja) | 2017-04-28 | 2026-03-18 | 小児の障害を処置する方法 |
Country Status (13)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3224280A1 (en) | 2014-11-26 | 2017-10-04 | Millennium Pharmaceuticals, Inc. | Vedolizumab for the treatment of fistulizing crohn's disease |
| US20230096620A1 (en) * | 2019-04-17 | 2023-03-30 | Millennium Pharmaceuticals, Inc. | Alpha4beta7 inhibitor and il-23 inhibitor combination therapy |
| CN115515435A (zh) * | 2020-02-11 | 2022-12-23 | 沃尔夫森医疗中心 | 有效治疗溃疡性结肠炎的方法 |
| EP4720125A1 (en) | 2023-05-30 | 2026-04-08 | Paragon Therapeutics, Inc. | Alpha4beta7 integrin antibody compositions and methods of use |
| EP4762093A1 (en) | 2023-08-14 | 2026-06-24 | Paragon Therapeutics, Inc. | Alpha 4 beta 7 integrin binding proteins and methods of use |
| WO2025177055A1 (en) * | 2024-02-20 | 2025-08-28 | Takeda Pharmaceutical Company Limited | Combination therapy for treating inflammatory bowel disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| JP3095168B2 (ja) | 1988-02-05 | 2000-10-03 | エル． モリソン，シェリー | ドメイン‐変性不変部を有する抗体 |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| US5840299A (en) | 1994-01-25 | 1998-11-24 | Athena Neurosciences, Inc. | Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| ATE366809T1 (de) | 1995-02-10 | 2007-08-15 | Millennium Pharm Inc | Addressine der schleimhaut und der blutgefässe und ihre verwendung |
| US7803904B2 (en) | 1995-09-01 | 2010-09-28 | Millennium Pharmaceuticals, Inc. | Mucosal vascular addressing and uses thereof |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| US6197582B1 (en) | 1998-03-18 | 2001-03-06 | The Trustees Of Columbia University In The City Of New York | Development of human monoclonal antibodies and uses thereof |
| AU2003248549B2 (en) | 2002-05-24 | 2010-04-08 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
| AU2003298661B2 (en) | 2002-11-18 | 2007-05-10 | Chemocentryx, Inc. | Aryl sulfonamides |
| ES2377979T3 (es) | 2004-09-03 | 2012-04-03 | Genentech, Inc. | Antagonistas anti-beta7 humanizados y utilizaciones para los mismos |
| EP1948691A1 (en) | 2005-11-17 | 2008-07-30 | Millennium Pharmaceuticals, Inc. | HUMANIZED IMMUNOGLOBULIN REACTIVE WITH a4ß7INTEGRIN |
| PE20120497A1 (es) | 2009-03-20 | 2012-05-14 | Amgen Inc | Anticuerpo antagonista especifico para el heterodimero de alfa-4-beta-7 |
| UA116189C2 (uk) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| UY34054A (es) * | 2011-05-02 | 2012-11-30 | Millennium Pharm Inc | FORMULACIÓN PARA ANTICUERPO ANTI-a(alfa)4B(Beta)7 |
| EP3978530A1 (en) * | 2015-02-26 | 2022-04-06 | F. Hoffmann-La Roche AG | Integrin beta7 antagonists and methods of treating crohn's disease |
| MA43755A (fr) * | 2016-03-14 | 2018-11-28 | Millennium Pharm Inc | Méthodes de traitement ou de prévention d'une maladie du greffon contre l'hôte |
-
2018
- 2018-04-26 IL IL270201A patent/IL270201B2/en unknown
- 2018-04-26 KR KR1020197030615A patent/KR20190141148A/ko not_active Ceased
- 2018-04-26 AU AU2018256840A patent/AU2018256840A1/en not_active Abandoned
- 2018-04-26 BR BR112019022268-5A patent/BR112019022268A2/pt unknown
- 2018-04-26 EP EP18728257.9A patent/EP3615071A2/en active Pending
- 2018-04-26 JP JP2019557637A patent/JP2020517671A/ja not_active Withdrawn
- 2018-04-26 WO PCT/US2018/029579 patent/WO2018200818A2/en not_active Ceased
- 2018-04-26 CA CA3061320A patent/CA3061320A1/en active Pending
- 2018-04-26 KR KR1020257028168A patent/KR20250134146A/ko active Pending
- 2018-04-26 CN CN201880027856.4A patent/CN110612120A/zh active Pending
- 2018-04-26 MX MX2019012749A patent/MX2019012749A/es unknown
- 2018-04-26 US US16/608,895 patent/US20200179486A1/en active Pending
- 2018-04-27 TW TW112126603A patent/TW202342102A/zh unknown
- 2018-04-27 TW TW107114371A patent/TWI811216B/zh active
- 2018-04-27 AR ARP180101099A patent/AR111491A1/es not_active Application Discontinuation
-
2019
- 2019-10-24 MX MX2024012972A patent/MX2024012972A/es unknown
- 2019-10-24 MX MX2024003905A patent/MX2024003905A/es unknown
- 2019-10-24 MX MX2024003906A patent/MX2024003906A/es unknown
-
2023
- 2023-05-10 JP JP2023077997A patent/JP2023113655A/ja active Pending
-
2025
- 2025-04-09 AU AU2025202525A patent/AU2025202525A1/en active Pending
-
2026
- 2026-03-18 JP JP2026045046A patent/JP2026120554A/ja active Pending